Results 11 to 20 of about 677,032 (302)

Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach [PDF]

open access: yes, 2011
Estimation of Influenza vaccine effectiveness (VE) varies with study design, clinical outcome 10 considered and statistical methodology used. By estimating VE using differing outcomes and 11 statistical methods on the same cohort of individuals the ...
Kavanagh, Kimberley   +8 more
core   +5 more sources

Influenza vaccines [PDF]

open access: yesVaccine, 2009
Influenza A viruses pose a substantial threat to the human population whether by purposeful manipulation and release or by the natural process of interspecies transmissions from animal reservoirs. The challenge with preparing for these events with vaccination strategies is that the best forms of protective immunity target the most variable of the viral
A H, Ellebedy, R J, Webby
openaire   +4 more sources

Successful Treatment of Complicated Influenza A(H3N2) Virus Infection and Rhabdomyolysis with Compassionate Use of IV Zanamivir

open access: yesPharmaceuticals, 2023
In 2019, EMA licensed intravenous (IV) zanamivir for severe influenza virus infection in children over 6 months as well as adults. Prior to that, it was possible via a compassionate use program.
Maren Alchikh   +3 more
doaj   +1 more source

Influenza and the influenza vaccine [PDF]

open access: yesCanadian Medical Association Journal, 2007
Influenza, or the “flu,” is an infection caused by the influenza virus. The virus infects the nose and throat, and it can sometimes spread to the lungs. Influenza commonly causes acute fever, cough, chills, tiredness, body aches and, in young children, ear aches.
Noni, MacDonald   +2 more
openaire   +2 more sources

Influenza Vaccination

open access: yesAnnals of Saudi Medicine, 1999
Nurses have an important part to play in dispelling myths about influenza vaccination and in actively encouraging older people to attend for vaccination. Irene Schofield discusses the issues.
A, Uma, P, Thirumalaikolundusubramanian
openaire   +5 more sources

Vaccines for Influenza [PDF]

open access: yesVaccines, 2021
Two reviews by Harding and Heaton [...]
Effie-Photini Tsilibary   +2 more
openaire   +3 more sources

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. [PDF]

open access: yes, 2011
Immunocompromised patients are vulnerable to severe or complicated influenza infection. Vaccination is widely recommended for this group. This systematic review and meta-analysis assesses influenza vaccination for immunocompromised patients in terms of ...
Kerac, Marko   +189 more
core   +6 more sources

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence [PDF]

open access: yes, 2012
Foremost amongst the diseases preventable by vaccination is influenza. Worldwide, influenza virus infection is associated with serious adverse events leading to hospitalization, debilitating complications, and death in elderly individuals ...
Assir N   +11 more
core   +1 more source

Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial [PDF]

open access: yes, 2010
Background: Current conventional vaccination approaches do not induce potent CD8 T-cell responses for fighting mostly variable viral diseases such as influenza, avian influenza viruses or HIV.
van der Werf, Sylvie   +39 more
core   +2 more sources

No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination

open access: yesVaccine: X, 2019
Influenza is a contagious respiratory illness caused by the influenza virus. The pandemic outbreak of influenza A H1N1 in 2009 (H1N1pdm09) gave us a unique opportunity to study humoral immune responses to a novel influenza vaccine strain.
Anders Madsen   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy